T1	Participants 69 95	Smith-Lemli-Opitz patients
T2	Participants 168 201	Smith-Lemli-Opitz syndrome (SLOS)
T3	Participants 545 573	23 children (aged 4-17 years
T4	Participants 753 787	participants with and without IEDs
